IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action

Sandrine Lecour, Ioanna Andreadou, Hans Erik Bøtker, Sean M. Davidson, Gerd Heusch, Marisol Ruiz-Meana, Rainer Schulz, Coert J. Zuurbier, Péter Ferdinandy, Derek J. Hausenloy*, Pavle Adamovski, Saime Batirel, Monika Barteková, Luc Bertrand, Christophe Beauloye, David Biedermann, Vilmante Borutaite, Stefan Chlopicki, Maija Dambrova, Sean DavidsonYvan Devaux, Fabio Di Lisa, Dragan Djuric, David Erlinge, Ines Falcao-Pires, Eleftheria Galatou, Alfonso Garcia-Sosa, Henrique Girao, Zoltan Giricz, Mariann Gyongyosi, Derek J. Hausenloy, Donagh Healy, Vladimir Jakovljevic, Jelena Jovanic, George Kararigas, Risto Kerkal, Frantisek Kolar, Brenda Kwak, Przemysław Leszek, Edgars Liepinsh, Jacob Lonborg, Sarah Longnus, Jasna Marinovic, Danina Mirela Muntean, Lana Nezic, Michel Ovize, Pasquale Pagliaro, Clarissa Pedrosa Da Costa Gomes, John Pernow, Andreas Persidis, on behalf of the European Union-CARDIOPROTECTION COST ACTION CA16225

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

65 Citations (Scopus)

Fingerprint

Dive into the research topics of 'IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action'. Together they form a unique fingerprint.

Medicine and Dentistry